Investment Summary |
|
|---|---|
| Date | 2016-10-06 |
| Target | GDI Isolation |
| Sector | Safety/Security |
| Investor(s) | Ciclad |
| Deal Type | Stake Purchase |
SEARCH BY
Ciclad SAS is a growth-oriented investment firm focused on majority and minority investments in French companies valued up to €50 million. Ciclad looks to commit €2 to €15 million per transaction and will consider a variety of investment situations including capital for growth, transfer of family-owned companies, divestitures, and recapitalizations. Ciclad does not have any sector preferences. Ciclad was formed in 1988 and has offices in Paris and Lyon.
| DEAL STATS | # |
|---|---|
| Overall | 20 of 50 |
| Sector: Safety/Security M&A | 1 of 1 |
| Type: Stake Purchase M&A Deals | 12 of 14 |
| Country: France M&A | 19 of 47 |
| Year: 2016 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-01-01 |
Edeis
Ivry-sur-Seine, France Edeis is an engineering consulting and project management company. The group supports its clients with innovative and sustainable solutions in areas as varied as urban management, mobility, digital, construction, industry, agri-food, health, private real estate, public facilities and infrastructure management. Edeis is based in Ivry-sur-Seine, France. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-01-02 |
ESO Paris Suposteo
Champs-sur-Marne, France ESO Paris Suposteo is the historic school for post-bac osteopathy training in France. Teaching is provided by a faculty of more than 160 speakers: French and foreign professional osteopaths, medical specialists, scientists, academics, researchers. The School has an integrated clinic with 38 consultation rooms and a research center. The osteopath diploma issued by ESO Paris is registered at RNCP level 1. |
Buy | - |
